Lv1
16 积分 2023-11-06 加入
PT101: A Treg selective agonist IL-2 mutein therapy for autoimmunity
10天前
已完结
Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
14天前
已完结
CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage
1个月前
已完结
Modification of kidney barrier function by the urokinase receptor
1个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2个月前
已完结
MHC/HLA Class I Loss in Cancer Cells
2个月前
已完结
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
2个月前
已完结
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer
2个月前
已完结
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
2个月前
已完结
Abstract 5553: Tumor-selective activation of 4-1BB receptor via bispecific antibody combinations
3个月前
已完结
皖公网安备34019202002308
